English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The safety and performance of the micra thranscatheter pacing system (MTPS) seems to be very high both in the investigational studies and in the real world setting. Much of currently available data comes from normal-sized adults, with only limited data on small-sized patients. We describe the MTPS implantation in a 71-year-old male, suffering from recurrent pacemaker infections and lead failure, who is affected by achondroplastic dwarfism with the pathognomonic phenotypical signs characterized by small size (height 120 cm; weight 39 kg), disproportionately short upper limbs, often limiting self-care skills, with an abnormal limb-to-trunk ratio. Other comorbidities include type 2 diabetes and severe thoracolumbar kyphosis. Previously, in 1970, the patient underwent a single-chamber pacemaker implantation via the right subclavian vein for complete atrioventricular block. Due to recurrent ventricular lead failure, a contralateral pacemaker implantation via the left subclavian vein was performed in

Leadless pacemaker implantation in achondroplastic dwarfism and recurrent cardiac implantable electronic device infections: a case report